TM

Thomas Jorg Mehrling

PP Purdue Pharmaceutical Products: 12 patents #1 of 29Top 4%
PP Purdue Pharma: 11 patents #38 of 189Top 25%
📍 Hünenberg, CH: #1 of 20 inventorsTop 5%
Overall (All Time): #177,913 of 4,157,543Top 5%
23
Patents All Time

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDate
12403130 Pharmaceutical combinations for treating cancer Enrique Maria Ocio 2025-09-02
12377076 Compounds for treating lymphoma or a T-cell malignant disease Katarina Hilgier, Francisco Ibanez Lopez 2025-08-05
12370177 Compounds for treating brain cancer Claudio Festuccia 2025-07-29
12370178 Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia Marco Herling 2025-07-29
12303492 Compounds for treating TNBC 2025-05-20
12257237 Tinostamustine for use in treating sarcoma 2025-03-25
12064417 Combination comprising a glucocorticoid and EDO-S101 Enrique Maria Ocio 2024-08-20
12048688 Pharmaceutical combinations for treating cancer Enrique Maria Ocio 2024-07-30
11918558 Tinostamustine for use in the treatment of T-cell prolymphocytic leukaemia Marco Herling 2024-03-05
11896583 Tinostamustine for use in treating ovarian cancer 2024-02-13
11786509 Compounds for treating TNBC 2023-10-17
11766424 Hodgkin lymphoma therapy Rosaria De Filippi, Antonio Pinto 2023-09-26
11576899 Tinostamustine for use in treating sarcoma 2023-02-14
11559516 Pharmaceutical combinations for treating cancer Enrique Maria Ocio 2023-01-24
11541038 Combination comprising a glucocorticoid and EDO-S101 Enrique Maria Ocio 2023-01-03
11419853 Compounds for treating brain cancer Claudio Festuccia 2022-08-23
11413276 Compounds for treating TNBC 2022-08-16
11401345 Humanized antibodies targeting human tissue factor Daniel A. Soltis, Richard Buick 2022-08-02
11318117 Tinostamustine for use in the treatment of t-cell prolymphocytic leukaemia Marco Herling 2022-05-03
11266631 Hodgkin lymphoma therapy Rosaria De Filippi, Antonio Pinto 2022-03-08
10744120 Combination comprising a glucocorticoid and EDO-S101 Enrique Maria Ocio 2020-08-18
10406138 Pharmaceutical combinations for treating cancer Enrique Maria Ocio 2019-09-10
9993482 Pharmaceutical combination comprising a class III receptor tyrosine kinase inhibitor and the alkylating histone-deacetylase inhibitor fusion molecule EDO-S101 together with its use in the treatment of cancer 2018-06-12